Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-08

Clinical Trial Update: Fenofibrate in Primary Biliary Cholangitis: a Real World Study [Phase 3]

View source ↗

Summary

A Phase 3 real-world study evaluating fenofibrate for primary biliary cholangitis is currently recruiting, led by Xijing Hospital of Digestive Diseases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FENOFIBRATE (Fenofibrate)

Snippet

Sponsor: Xijing Hospital of Digestive Diseases | Conditions: Primary Biliary Cholangitis (PBC) | Phase 3 | Status: RECRUITING